MaxCyte Inc. Common Stock

MaxCyte Inc. a life sciences company discovers develops and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx a static electroporation instrument for small to medium scale transfection; ExPERT STx a flow electroporation for protein production and drug development as well as expression of therapeutic targets for cell-based assays; ExPERT GTx a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies as well as to pharmaceutical and biotechnology companies for use in drug discovery and development and bio-manufacturing. The company was incorporated in 1998 and is headquartered in Rockville Maryland.